The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(4-(4-Chlorophenyl)piperazin-1-yl)(thiomorpholino)methanone ID: ALA3103341
PubChem CID: 76324692
Max Phase: Preclinical
Molecular Formula: C15H20ClN3OS
Molecular Weight: 325.87
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(N1CCSCC1)N1CCN(c2ccc(Cl)cc2)CC1
Standard InChI: InChI=1S/C15H20ClN3OS/c16-13-1-3-14(4-2-13)17-5-7-18(8-6-17)15(20)19-9-11-21-12-10-19/h1-4H,5-12H2
Standard InChI Key: OXCXCDMSPPIXFG-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
29.5372 -24.6560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5360 -25.4756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2441 -25.8845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9537 -25.4751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9509 -24.6524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2423 -24.2472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6571 -24.2412 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.3636 -24.6494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0677 -24.2416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0688 -23.4240 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.3597 -23.0159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6495 -23.4254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7765 -23.0154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4843 -23.4241 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.7766 -22.1983 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.8280 -25.8836 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
34.4809 -24.2400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1845 -24.6485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8947 -24.2434 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
35.8966 -23.4252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1885 -23.0122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
7 12 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
10 13 1 0
13 14 1 0
13 15 2 0
2 16 1 0
14 17 1 0
14 21 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 325.87Molecular Weight (Monoisotopic): 325.1016AlogP: 2.63#Rotatable Bonds: 1Polar Surface Area: 26.79Molecular Species: NEUTRALHBA: 3HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 2.68CX LogP: 2.23CX LogD: 2.23Aromatic Rings: 1Heavy Atoms: 21QED Weighted: 0.79Np Likeness Score: -1.79
References 1. Flanagan JU, Atwell GJ, Heinrich DM, Brooke DG, Silva S, Rigoreau LJ, Trivier E, Turnbull AP, Raynham T, Jamieson SM, Denny WA.. (2014) Morpholylureas are a new class of potent and selective inhibitors of the type 5 17-β-hydroxysteroid dehydrogenase (AKR1C3)., 22 (3): [PMID:24411201 ] [10.1016/j.bmc.2013.12.050 ] 2. Endo, Satoshi S and 16 more authors. 2017-10-26 Synthesis of Potent and Selective Inhibitors of Aldo-Keto Reductase 1B10 and Their Efficacy against Proliferation, Metastasis, and Cisplatin Resistance of Lung Cancer Cells. [PMID:28976752 ]